Qingqing Shan

Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway

Yong Guo, Qingqing Shan, Yuping Gong et al. · Cancer Biology & Therapy · 2012 · 47 citations · Full text

Hematological Malignancy, Tumor Biology, Ph+ All +13

Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia

Yong Guo, Yi Li, Qingqing Shan et al. · The International Journal of Biochemistry & Cell Biology · 2015 · 43 citations

Hematological Malignancy, Bcr/abl Gene Expression, Medicine +8

Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.

Yong Guo, Qingqing Shan, Yuping Gong et al. · PubMed · 2014 · 28 citations

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma

Qingqing Shan, Chi Zhang, Yangke Li et al. · Scientific Reports · 2023 · 16 citations · Full text

Lung Adenocarcinoma, Immunology, Slc7a11-low Group +16

Antileukaemia effect of rapamycin alone or in combination with daunorubicin on ph+ acute lymphoblastic leukaemia cell line

Xi Yang, Juan Lin, Yuping Gong et al. · Hematological Oncology · 2011 · 11 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +17